Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals Net Income 2010-2023 | VRTX

Vertex Pharmaceuticals annual/quarterly net income history and growth rate from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Vertex Pharmaceuticals net income for the quarter ending December 31, 2023 was $0.969B, a 18.31% increase year-over-year.
  • Vertex Pharmaceuticals net income for the twelve months ending December 31, 2023 was $3.620B, a 8.96% increase year-over-year.
  • Vertex Pharmaceuticals annual net income for 2023 was $3.62B, a 8.96% increase from 2022.
  • Vertex Pharmaceuticals annual net income for 2022 was $3.322B, a 41.84% increase from 2021.
  • Vertex Pharmaceuticals annual net income for 2021 was $2.342B, a 13.63% decline from 2020.
  
Vertex Pharmaceuticals Annual Net Income
(Millions of US $)
2023 $3,620
2022 $3,322
2021 $2,342
2020 $2,712
2019 $1,177
2018 $2,097
2017 $263
2016 $-112
2015 $-556
2014 $-739
2013 $-445
2012 $-107
2011 $30
2010 $-755
2009 $-642
Vertex Pharmaceuticals Quarterly Net Income
(Millions of US $)
2023-12-31 $969
2023-09-30 $1,035
2023-06-30 $916
2023-03-31 $700
2022-12-31 $819
2022-09-30 $931
2022-06-30 $811
2022-03-31 $762
2021-12-31 $770
2021-09-30 $852
2021-06-30 $67
2021-03-31 $653
2020-12-31 $604
2020-09-30 $667
2020-06-30 $837
2020-03-31 $603
2019-12-31 $583
2019-09-30 $58
2019-06-30 $267
2019-03-31 $269
2018-12-31 $1,551
2018-09-30 $129
2018-06-30 $207
2018-03-31 $210
2017-12-31 $101
2017-09-30 $-103
2017-06-30 $18
2017-03-31 $248
2016-12-31 $33
2016-09-30 $-39
2016-06-30 $-65
2016-03-31 $-42
2015-12-31 $-74
2015-09-30 $-95
2015-06-30 $-189
2015-03-31 $-199
2014-12-31 $-177
2014-09-30 $-170
2014-06-30 $-159
2014-03-31 $-232
2013-12-31 $44
2013-09-30 $-124
2013-06-30 $-57
2013-03-31 $-308
2012-12-31 $-75
2012-09-30 $-58
2012-06-30 $-65
2012-03-31 $91
2011-12-31 $159
2011-09-30 $221
2011-06-30 $-174
2011-03-31 $-176
2010-12-31 $-180
2010-09-30 $-209
2010-06-30 $-200
2010-03-31 $-165
2009-12-31 $-159
2009-09-30 $-150
2009-06-30 $-171
2009-03-31 $-163
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $112.896B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $171.144B 17.12
Regeneron Pharmaceuticals (REGN) United States $107.785B 26.36
GSK (GSK) United Kingdom $94.711B 11.31
CSL (CSLLY) Australia $91.789B 0.00
Bristol Myers Squibb (BMY) United States $90.307B 42.43
Gilead Sciences (GILD) United States $83.485B 16.63
Moderna (MRNA) United States $49.461B 0.00
Biogen (BIIB) United States $34.262B 15.69
Argenex SE (ARGX) Netherlands $22.403B 0.00
BioNTech SE (BNTX) Germany $21.918B 184.40
Genmab (GMAB) Denmark $19.982B 23.43
Alnylam Pharmaceuticals (ALNY) United States $18.645B 0.00
Illumina (ILMN) United States $18.321B 130.69
BeiGene (BGNE) Cayman Islands $15.777B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.266B 59.56
Bio-Techne Corp (TECH) United States $13.158B 49.70
Incyte (INCY) United States $12.810B 19.81
Sarepta Therapeutics (SRPT) United States $12.524B 1104.17
QIAGEN (QGEN) Netherlands $10.445B 22.31
Exact Sciences (EXAS) United States $9.843B 0.00
Repligen (RGEN) United States $9.836B 128.49
Roivant Sciences (ROIV) United Kingdom $9.267B 0.00
Viking Therapeutics (VKTX) United States $8.602B 0.00
Legend Biotech (LEGN) United States $8.324B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 26.11
Vaxcyte (PCVX) United States $7.793B 0.00
Ascendis Pharma (ASND) Denmark $7.222B 0.00
Intra-Cellular Therapies (ITCI) United States $7.057B 0.00
Blueprint Medicines (BPMC) United States $6.536B 0.00
Exelixis (EXEL) United States $6.404B 33.00
Cytokinetics (CYTK) United States $6.344B 0.00
Halozyme Therapeutics (HALO) United States $5.832B 16.19
ImmunityBio (IBRX) United States $5.602B 0.00
Apellis Pharmaceuticals (APLS) United States $5.088B 0.00
Zealand Pharma (ZLDPF) Denmark $4.909B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.837B 0.00
Krystal Biotech (KRYS) United States $4.660B 0.00
Nuvalent (NUVL) United States $4.592B 0.00
Immunovant (IMVT) United States $4.494B 0.00
Alkermes (ALKS) Ireland $4.085B 15.99
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.755B 0.00
Insmed (INSM) United States $3.705B 0.00
Axsome Therapeutics (AXSM) United States $3.606B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.418B 0.00
SpringWorks Therapeutics (SWTX) United States $3.349B 0.00
Biohaven (BHVN) United States $3.274B 0.00
IDEAYA Biosciences (IDYA) United States $3.212B 0.00
Guardant Health (GH) United States $3.151B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.053B 0.00
Iovance Biotherapeutics (IOVA) United States $2.989B 0.00
Denali Therapeutics (DNLI) United States $2.975B 0.00
Amicus Therapeutics (FOLD) United States $2.861B 0.00
Avidity Biosciences (RNA) United States $2.822B 0.00
Twist Bioscience (TWST) United States $2.816B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.790B 0.00
MorphoSys AG (MOR) Germany $2.786B 0.00
Arcellx (ACLX) United States $2.767B 0.00
Merus (MRUS) Netherlands $2.653B 0.00
Celldex Therapeutics (CLDX) United States $2.648B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.600B 0.00
Fortrea Holdings (FTRE) United States $2.571B 31.61
Certara (CERT) United States $2.561B 58.96
Intellia Therapeutics (NTLA) United States $2.530B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.498B 0.00
Janux Therapeutics (JANX) United States $2.462B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.415B 0.00
Vericel (VCEL) United States $2.401B 0.00
Apogee Therapeutics (APGE) United States $2.397B 0.00
Vera Therapeutics (VERA) United States $2.325B 0.00
Geron (GERN) United States $2.313B 0.00
Myriad Genetics (MYGN) United States $2.232B 0.00
Arvinas (ARVN) United States $2.212B 0.00
Kymera Therapeutics (KYMR) United States $2.205B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.201B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.148B 0.00
ADMA Biologics Inc (ADMA) United States $2.077B 82.73
Zai Lab (ZLAB) China $2.069B 0.00
Sana Biotechnology (SANA) United States $2.053B 0.00
Beam Therapeutics (BEAM) United States $1.985B 0.00
Keros Therapeutics (KROS) United States $1.963B 0.00
Bavarian Nordic (BVNRY) Denmark $1.937B 8.43
NeoGenomics (NEO) United States $1.932B 0.00
Galapagos (GLPG) Belgium $1.916B 0.00
CG Oncology (CGON) United States $1.867B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.865B 0.00
Protagonist Therapeutics (PTGX) United States $1.846B 12.90
Novavax (NVAX) United States $1.811B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.806B 0.00
Inhibrx (INBX) United States $1.801B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.687B 12.86
Structure Therapeutics (GPCR) United States $1.682B 0.00
Kura Oncology (KURA) United States $1.666B 0.00
Edgewise Therapeutics (EWTX) United States $1.651B 0.00
Arcus Biosciences (RCUS) United States $1.596B 0.00
Ligand Pharmaceuticals (LGND) United States $1.544B 25.23
Neumora Therapeutics (NMRA) United States $1.543B 0.00
Morphic Holding (MORF) United States $1.514B 0.00
Spyre Therapeutics (SYRE) United States $1.506B 0.00
Akero Therapeutics (AKRO) United States $1.457B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.455B 0.00
Dynavax Technologies (DVAX) United States $1.445B 184.00
Day One Biopharmaceuticals (DAWN) United States $1.435B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.426B 0.00
ANI Pharmaceuticals (ANIP) United States $1.366B 16.88
Vir Biotechnology (VIR) United States $1.363B 0.00
Gyre Therapeutics (GYRE) United States $1.337B 0.00
Belite Bio (BLTE) United States $1.237B 0.00
MannKind (MNKD) United States $1.212B 148.33
Prothena (PRTA) Ireland $1.204B 0.00
MiMedx (MDXG) United States $1.193B 50.50
Mirum Pharmaceuticals (MIRM) United States $1.178B 0.00
Cullinan Therapeutics (CGEM) United States $1.151B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.127B 0.00
Scholar Rock Holding (SRRK) United States $1.120B 0.00
AbCellera Biologics (ABCL) Canada $1.088B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.070B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.045B 0.00
Tyra Biosciences (TYRA) United States $0.969B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.957B 0.00
Liquidia Technologies (LQDA) United States $0.939B 0.00
Immatics (IMTX) Germany $0.938B 0.00
Pliant Therapeutics (PLRX) United States $0.927B 0.00
Viridian Therapeutics (VRDN) United States $0.911B 0.00
89BIO (ETNB) United States $0.905B 0.00
Immunome (IMNM) United States $0.888B 0.00
Abivax SA (ABVX) France $0.878B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.851B 0.00
Tango Therapeutics (TNGX) United States $0.833B 0.00
CARGO Therapeutics (CRGX) United States $0.827B 0.00
Mesoblast (MESO) Australia $0.822B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.822B 0.00
Dianthus Therapeutics (DNTH) United States $0.813B 0.00
Prime Medicine (PRME) United States $0.811B 0.00
Cytek Biosciences (CTKB) United States $0.801B 0.00
REGENXBIO (RGNX) United States $0.799B 0.00
Disc Medicine (IRON) United States $0.786B 0.00
ALX Oncology Holdings (ALXO) United States $0.783B 0.00
Nurix Therapeutics (NRIX) United States $0.782B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.781B 0.00
PureTech Health (PRTC) United States $0.771B 0.00
Humacyte (HUMA) United States $0.770B 0.00
Praxis Precision Medicines (PRAX) United States $0.753B 0.00
HilleVax (HLVX) United States $0.751B 0.00
Cogent Biosciences (COGT) United States $0.738B 0.00
Stoke Therapeutics (STOK) United States $0.736B 0.00
WAVE Life Sciences (WVE) Singapore $0.723B 0.00
Nuvation Bio (NUVB) United States $0.720B 0.00
CureVac (CVAC) Germany $0.714B 0.00
AnaptysBio (ANAB) United States $0.699B 0.00
Kyverna Therapeutics (KYTX) United States $0.684B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.674B 0.00
Castle Biosciences (CSTL) United States $0.673B 0.00
GH Research (GHRS) Ireland $0.663B 0.00
ArriVent BioPharma (AVBP) United States $0.653B 0.00
Mineralys Therapeutics (MLYS) United States $0.649B 0.00
ITeos Therapeutics (ITOS) United States $0.649B 0.00
Zymeworks (ZYME) United States $0.647B 0.00
Pharming Group (PHAR) Netherlands $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.637B 0.00
Oric Pharmaceuticals (ORIC) United States $0.628B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.609B 0.00
Aerovate Therapeutics (AVTE) United States $0.605B 0.00
Cabaletta Bio (CABA) United States $0.594B 0.00
EnGene Holdings (ENGN) United States $0.594B 0.00
Northwest Biotherapeutics (NWBO) United States $0.593B 0.00
Avid Bioservices (CDMO) United States $0.587B 0.00
Adaptive Biotechnologies (ADPT) United States $0.575B 0.00
IGM Biosciences (IGMS) United States $0.558B 0.00
Olema Pharmaceuticals (OLMA) United States $0.551B 0.00
Absci (ABSI) United States $0.546B 0.00
Alector (ALEC) United States $0.545B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.534B 0.00
Arbutus Biopharma (ABUS) United States $0.530B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Third Harmonic Bio (THRD) United States $0.527B 0.00
Celcuity (CELC) United States $0.525B 0.00
Travere Therapeutics (TVTX) United States $0.518B 0.00
Adlai Nortye (ANL) Cayman Islands $0.514B 0.00
Fulcrum Therapeutics (FULC) United States $0.513B 0.00
Allogene Therapeutics (ALLO) United States $0.509B 0.00
Astria Therapeutics (ATXS) United States $0.509B 0.00
Ocugen (OCGN) United States $0.504B 0.00
Applied Therapeutics (APLT) United States $0.503B 0.00
MaxCyte (MXCT) United States $0.499B 0.00
Editas Medicine (EDIT) United States $0.493B 0.00
Entrada Therapeutics (TRDA) United States $0.489B 23.00
Oculis Holding AG (OCS) Switzerland $0.486B 0.00
Fate Therapeutics (FATE) United States $0.483B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.478B 0.00
Biomea Fusion (BMEA) United States $0.476B 0.00
ACELYRIN, INC (SLRN) United States $0.469B 0.00
Voyager Therapeutics (VYGR) United States $0.466B 0.00
PepGen (PEPG) United States $0.448B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.445B 0.00
Neurogene (NGNE) United States $0.436B 0.00
TScan Therapeutics (TCRX) United States $0.428B 0.00
C4 Therapeutics (CCCC) United States $0.420B 0.00
Replimune (REPL) United States $0.418B 0.00
Candel Therapeutics (CADL) United States $0.416B 0.00
Annexon (ANNX) United States $0.416B 0.00
Shattuck Labs (STTK) United States $0.388B 0.00
Terns Pharmaceuticals (TERN) United States $0.387B 0.00
Anika Therapeutics (ANIK) United States $0.387B 326.00
Amarin (AMRN) Ireland $0.384B 0.00
Anavex Life Sciences (AVXL) United States $0.380B 0.00
FibroBiologics (FBLG) United States $0.376B 0.00
Alto Neuroscience (ANRO) United States $0.372B 0.00
Aura Biosciences (AURA) United States $0.372B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.372B 0.00
Solid Biosciences (SLDB) United States $0.367B 0.00
Precigen (PGEN) United States $0.363B 0.00
Nautilus Biotechnology (NAUT) United States $0.360B 0.00
MeiraGTx Holdings (MGTX) United States $0.356B 0.00
AC Immune (ACIU) Switzerland $0.347B 0.00
Revance Therapeutics (RVNC) United States $0.346B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.342B 0.00
Nkarta (NKTX) United States $0.340B 0.00
Inovio Pharmaceuticals (INO) United States $0.339B 0.00
Poseida Therapeutics (PSTX) United States $0.335B 0.00
Tenaya Therapeutics (TNYA) United States $0.334B 0.00
Verastem (VSTM) United States $0.332B 0.00
Caribou Biosciences (CRBU) United States $0.329B 0.00
Erasca (ERAS) United States $0.328B 0.00
Jasper Therapeutics (JSPR) United States $0.325B 0.00
Urogen Pharma (URGN) United States $0.323B 0.00
Kamada (KMDA) Israel $0.321B 24.30
Mersana Therapeutics (MRSN) United States $0.314B 0.00
Atea Pharmaceuticals (AVIR) United States $0.312B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.312B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.306B 0.00
Emergent Biosolutions (EBS) United States $0.299B 0.00
Ventyx Biosciences (VTYX) United States $0.295B 0.00
Invivyd (IVVD) United States $0.294B 0.00
Inozyme Pharma (INZY) United States $0.289B 0.00
CorMedix Inc (CRMD) United States $0.289B 0.00
XOMA (XOMA) United States $0.288B 0.00
23andMe Holding (ME) United States $0.283B 0.00
Contineum Therapeutics (CTNM) United States $0.280B 0.00
Rani Therapeutics Holdings (RANI) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.274B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.264B 0.00
XBiotech (XBIT) United States $0.262B 0.00
Codexis (CDXS) United States $0.261B 0.00
Design Therapeutics (DSGN) United States $0.255B 0.00
2seventy Bio (TSVT) United States $0.250B 0.00
Coherus BioSciences (CHRS) United States $0.250B 0.00
Prima BioMed (IMMP) Australia $0.248B 0.00
UniQure (QURE) Netherlands $0.246B 0.00
Sutro Biopharma (STRO) United States $0.245B 0.00
G1 Therapeutics (GTHX) United States $0.245B 0.00
Ovid Therapeutics (OVID) United States $0.236B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.228B 0.00
Agenus (AGEN) United States $0.226B 0.00
INmune Bio (INMB) United States $0.225B 0.00
Puma Biotechnology (PBYI) United States $0.224B 14.09
Zura Bio (ZURA) United States $0.224B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.220B 0.00
Boundless Bio (BOLD) $0.212B 0.00
Compass Therapeutics (CMPX) United States $0.212B 0.00
Werewolf Therapeutics (HOWL) United States $0.211B 0.00
Opthea (OPT) Australia $0.209B 0.00
Elevation Oncology (ELEV) United States $0.204B 0.00
Innate Pharma S.A (IPHA) France $0.203B 0.00
Kodiak Sciences (KOD) United States $0.196B 0.00
Inventiva S.A (IVA) France $0.196B 0.00
Trevi Therapeutics (TRVI) United States $0.195B 0.00
Compugen (CGEN) Israel $0.191B 0.00
Greenwich LifeSciences (GLSI) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.189B 0.00
Lifecore Biomedical (LFCR) United States $0.182B 0.00
Adverum Biotechnologies (ADVM) United States $0.182B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.172B 0.00
Alimera Sciences (ALIM) United States $0.171B 0.00
Cellectis S.A (CLLS) France $0.170B 0.00
Adocia (ADOCY) France $0.170B 0.00
Gossamer Bio (GOSS) United States $0.168B 0.00
ScPharmaceuticals (SCPH) United States $0.165B 0.00
X4 Pharmaceuticals (XFOR) United States $0.164B 0.00
Cardiff Oncology (CRDF) United States $0.160B 0.00
BioStem Technologies (BSEM) $0.158B 0.00
Skye Bioscience (SKYE) United States $0.157B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.155B 0.00
CytomX Therapeutics (CTMX) United States $0.153B 9.80
CervoMed (CRVO) United States $0.153B 0.00
Repare Therapeutics (RPTX) Canada $0.152B 0.00
Scilex Holding (SCLX) United States $0.148B 0.00
Rapt Therapeutics (RAPT) United States $0.148B 0.00
Sagimet Biosciences (SGMT) United States $0.147B 0.00
TELA Bio (TELA) United States $0.147B 0.00
Syros Pharmaceuticals (SYRS) United States $0.147B 0.00
I-Mab (IMAB) China $0.147B 0.00
Seres Therapeutics (MCRB) United States $0.145B 0.00
BioAtla (BCAB) United States $0.144B 0.00
Cartesian Therapeutics (RNAC) United States $0.142B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.139B 0.00
Seer (SEER) United States $0.139B 0.00
Akoya Biosciences (AKYA) United States $0.138B 0.00
Renovaro (RENB) United States $0.136B 0.00
Molecular Partners AG (MOLN) Switzerland $0.135B 0.00
ATyr Pharma (LIFE) United States $0.132B 0.00
Vigil Neuroscience (VIGL) United States $0.131B 0.00
Abeona Therapeutics (ABEO) United States $0.129B 0.00
PDS Biotechnology (PDSB) United States $0.128B 0.00
Omega Therapeutics (OMGA) United States $0.126B 0.00
VistaGen Therapeutics (VTGN) United States $0.124B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
Nuvectis Pharma (NVCT) United States $0.122B 0.00
Sangamo Therapeutics (SGMO) United States $0.120B 0.00
Vor Biopharma (VOR) $0.119B 0.00
China Health Industries Holdings (CHHE) China $0.118B 0.00
Adagene (ADAG) China $0.117B 0.00
Bluebird Bio (BLUE) United States $0.117B 0.00
Immunic (IMUX) United States $0.117B 0.00
Adicet Bio (ACET) United States $0.115B 0.00
DiaMedica Therapeutics (DMAC) United States $0.114B 0.00
DBV Technologies S.A (DBVT) France $0.111B 0.00
BeyondSpring (BYSI) United States $0.110B 0.00
Elicio Therapeutics (ELTX) United States $0.106B 0.00
Rezolute (RZLT) United States $0.106B 0.00
Allakos (ALLK) United States $0.105B 0.00
BioHarvest Sciences (CNVCF) Canada $0.101B 0.00
Connect Biopharma Holdings (CNTB) United States $0.100B 0.00
Clearside Biomedical (CLSD) United States $0.099B 0.00
Genelux (GNLX) United States $0.098B 0.00
Annovis Bio (ANVS) United States $0.097B 0.00
Oncobiologics (OTLK) United States $0.097B 0.00
YS Biopharma (YS) China $0.096B 0.00
Q32 Bio (QTTB) United States $0.096B 0.00
IO Biotech (IOBT) Denmark $0.094B 0.00
Eton Pharmaceuticals (ETON) United States $0.094B 91.25
ANIXA BIOSCIENCES INC (ANIX) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Oncolytics Biotech (ONCY) Canada $0.088B 0.00
Spero Therapeutics (SPRO) United States $0.087B 3.18
Barinthus Biotherapeutics (BRNS) United Kingdom $0.087B 0.00
HOOKIPA Pharma (HOOK) United States $0.085B 0.00
Galena Biopharma (SLS) United States $0.085B 0.00
Athira Pharma (ATHA) United States $0.085B 0.00
Precision BioSciences (DTIL) United States $0.084B 0.00
Benitec Biopharma (BNTC) United States $0.083B 0.00
InflaRx (IFRX) Germany $0.082B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
Gritstone Bio (GRTS) United States $0.081B 0.00
Affimed (AFMD) Germany $0.081B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.081B 0.00
Cue Biopharma (CUE) United States $0.080B 0.00
Elutia (ELUT) United States $0.080B 0.00
Rallybio (RLYB) United States $0.079B 0.00
Passage Bio (PASG) United States $0.079B 0.00
Instil Bio (TIL) United States $0.079B 0.00
Cognition Therapeutics (CGTX) United States $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
BioXcel Therapeutics (BTAI) United States $0.077B 0.00
Atara Biotherapeutics (ATRA) United States $0.077B 0.00
Bionano Genomics (BNGO) United States $0.077B 0.00
Alpha Teknova (TKNO) United States $0.077B 0.00
Curis (CRIS) United States $0.077B 0.00
Entera Bio (ENTX) Israel $0.075B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.073B 0.00
MediciNova (MNOV) United States $0.073B 0.00
Leap Therapeutics (LPTX) United States $0.072B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
Lantern Pharma (LTRN) United States $0.068B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.068B 0.00
AN2 Therapeutics (ANTX) United States $0.068B 0.00
Intensity Therapeutics (INTS) United States $0.066B 0.00
Aileron Therapeutics (ALRN) United States $0.066B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.065B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
Celularity (CELU) United States $0.064B 0.00
Turnstone Biologics (TSBX) United States $0.064B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.062B 0.00
Immix Biopharma (IMMX) United States $0.062B 0.00
AVROBIO (AVRO) United States $0.062B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.060B 0.00
Ocean Biomedical (OCEA) United States $0.060B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
CalciMedica (CALC) United States $0.059B 0.00
Genenta Science S.p.A (GNTA) Italy $0.058B 0.00
Checkpoint Therapeutics (CKPT) United States $0.058B 0.00
Cidara Therapeutics (CDTX) United States $0.058B 0.00
LENZ Therapeutics (LENZ) United States $0.058B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
Kezar Life Sciences (KZR) United States $0.056B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.055B 0.00
Equillium (EQ) United States $0.054B 0.00
Eyenovia (EYEN) United States $0.054B 0.00
ARCA Biopharma (ABIO) United States $0.054B 0.00
Aligos Therapeutics (ALGS) United States $0.051B 0.00
IN8bio (INAB) United States $0.050B 0.00
Clene (CLNN) United States $0.049B 0.00
Immuneering (IMRX) United States $0.047B 0.00
NextCure (NXTC) United States $0.046B 0.00
Dyadic (DYAI) United States $0.046B 0.00
Aadi Bioscience (AADI) United States $0.045B 0.00
Ocuphire Pharma (OCUP) United States $0.045B 0.00
Carmell (CTCX) United States $0.045B 0.00
HCW Biologics (HCWB) United States $0.044B 0.00
Beyond Air (XAIR) United States $0.043B 0.00
OKYO Pharma (OKYO) $0.043B 0.00
Cara Therapeutics (CARA) United States $0.042B 0.00
Xilio Therapeutics (XLO) United States $0.041B 0.00
Cyclo Therapeutics (CYTH) United States $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.040B 0.00
Estrella Immunopharma (ESLA) United States $0.040B 0.00
Quince Therapeutics (QNCX) United States $0.039B 0.00
Sensei Biotherapeutics (SNSE) United States $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
Dare Bioscience (DARE) United States $0.036B 0.00
MiNK Therapeutics (INKT) United States $0.036B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.036B 0.00
Promis Neurosciences (PMN) Canada $0.034B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.034B 0.00
Fortress Biotech (FBIO) United States $0.033B 0.00
Spruce Biosciences (SPRB) United States $0.033B 0.00
Pluri (PLUR) Israel $0.033B 0.00
Theratechnologies (THTX) Canada $0.032B 0.00
Bolt Biotherapeutics (BOLT) United States $0.032B 0.00
Aprea Therapeutics (APRE) United States $0.032B 0.00
Apollomics (APLM) United States $0.031B 0.00
Femasys (FEMY) United States $0.030B 0.00
Evogene (EVGN) Israel $0.028B 0.00
BRIACELL THERAP (BCTX) Canada $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Biora Therapeutics (BIOR) United States $0.026B 0.00
NKGen Biotech (NKGN) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
RenovoRx (RNXT) United States $0.023B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
BioAffinity Technologies (BIAF) United States $0.022B 0.00
Cocrystal Pharma (COCP) United States $0.021B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.021B 0.00
Synlogic (SYBX) United States $0.020B 0.00
Orgenesis (ORGS) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
KALA BIO (KALA) United States $0.019B 0.00
VBI Vaccines (VBIV) United States $0.019B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.018B 0.00
Lumos Pharma (LUMO) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.017B 0.00
Galecto (GLTO) Denmark $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Vincerx Pharma (VINC) United States $0.016B 0.00
Semper Paratus Acquisition (TVGN) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Imunon (IMNN) United States $0.013B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
ABVC BioPharma (ABVC) United States $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Monopar Therapeutics (MNPR) United States $0.010B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
NuCana (NCNA) United Kingdom $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Telesis Bio (TBIO) United States $0.008B 0.00
AquaBounty Technologies (AQB) United States $0.008B 0.00
Trevena (TRVN) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Kintara Therapeutics (KTRA) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
First Wave BioPharma (FWBI) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Kineta (KA) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
ThermoGenesis Holdings (THMO) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Seelos Therapeutics (SEEL) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.47
Exicure (XCUR) United States $0.004B 0.30
Alzamend Neuro (ALZN) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
Longeveron (LGVN) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00